Co-Diagnostics Inc develops principal design work on monkeypox PCR test
Co-Diagnostics (NASDAQ:CODX) Inc, a molecular diagnostics company, has completed the principal design work on a PCR test for the monkeypox virus, the...
Stay updated with breaking news from Dwight Egan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Co-Diagnostics (NASDAQ:CODX) Inc, a molecular diagnostics company, has completed the principal design work on a PCR test for the monkeypox virus, the...
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...
Co-Diagnostics (NASDAQ:CODX) Inc, a molecular diagnostics company, has completed the principal design work on a PCR test for the monkeypox virus, the...
The company is not monkeying around with the latest possible global health menace.
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...